Core Insights - Eight new stocks were listed last week, including one direct listing company, raising significant capital across various sectors [1][2][3]. Group 1: Recent IPOs - MapLight Therapeutics (MPLT) raised $251 million by issuing 14.75 million shares at $17 each [1]. - Navan (NAVN) raised $923 million by issuing 36.92 million shares at $25 each [1]. - Boyd Group Services (BGSI) raised $780 million by issuing 5.5 million shares at $141 each [2]. - Nomadar (NOMA) entered Nasdaq through a direct listing [3]. Group 2: Upcoming IPOs - BETA Technologies, Inc. plans to list on NYSE with a target date of November 4, 2025, aiming to raise approximately $825 million by issuing 25 million shares at $27 to $33 each. The company reported revenue of $15.57 million in the first half of 2025, up from $7.59 million in the same period last year, with a net loss of $159 million [4][6]. - Exzeo Group, Inc. plans to list on NYSE on November 5, 2025, aiming to raise about $176 million by issuing 8 million shares at $20 to $22 each. The company reported revenue of $109 million in the first half of 2025, up from $60.31 million year-over-year, with a net profit of $39.61 million [6][8]. - Evommune, Inc. plans to list on NYSE on November 6, 2025, aiming to raise approximately $159 million by issuing 9.38 million shares at $15 to $17 each. The company reported revenue of $3 million in the first half of 2025, down from $7 million year-over-year, with a net loss of $28.12 million [10]. - Grupo Aeroméxico, S.A.B. de C.V. plans to list on NYSE on November 6, 2025, aiming to raise about $235 million by issuing 11.73 million shares at $18 to $20 each. The company reported revenue of $2.498 billion in the first half of 2025, down from $2.695 billion year-over-year, with a net profit of $89.97 million [12]. - BillionToOne, Inc. plans to list on NASDAQ on November 6, 2025, aiming to raise approximately $212 million by issuing 3.85 million shares at $49 to $55 each. The company reported revenue of $126 million in the first half of 2025, up from $69.09 million year-over-year, with a net loss of $4.23 million [14]. - Off The Hook YS Inc. plans to list on NYSE MKT on November 7, 2025, aiming to raise about $30 million by issuing 5 million shares at $4 to $6 each. The company reported revenue of $58.59 million in the first half of 2025, up from $51.85 million year-over-year, with a net profit of $840,000 [16].

Core Viewpoint - Exzeo Group, a US-based insurance technology company, is planning an IPO aiming for a valuation of up to $2 billion, seeking to raise approximately $176 million by issuing eight million shares priced between $20 and $22 each [1][2]. Group 1: IPO Details - The company will offer all primary shares, with HCI Group maintaining majority ownership post-listing [3]. - Underwriters have been granted a 30-day option to purchase an additional 1.2 million shares at the IPO price, along with applicable discounts and commissions [3]. - Exzeo intends to list its common stock on the New York Stock Exchange under the ticker symbol 'XZO' [3]. Group 2: Regulatory Context - The SEC has recently relaxed rules to facilitate IPOs during the ongoing government shutdown, although legal advisers suggest this change may not lead to a significant increase in offerings [2]. - The registration statement for the IPO is expected to automatically become effective on November 4, 2025, unless further SEC action occurs [4]. Group 3: Company Background - HCI Group, the parent company of Exzeo, consists of two distinct units: one includes multiple insurance companies and a captive reinsurance company, while the second unit, Exzeo Group, focuses on advanced underwriting algorithms and data analytics for property and casualty insurers [5]. - Exzeo was previously known as TypTap Insurance and had submitted a draft registration for a US IPO in 2021 but abandoned the plan in 2023 [5].

Core Viewpoint - HCI Group, Inc. has announced the IPO launch of its subsidiary Exzeo Group, Inc., retaining majority ownership post-IPO [1] Group 1: IPO Details - Exzeo is offering 8.0 million shares of common stock in the IPO, all of which are primary shares [1] - The IPO price is expected to be between $20.00 and $22.00 per share [3] - Exzeo has applied to list its common stock on the New York Stock Exchange under the ticker symbol "XZO" [3] Group 2: Underwriter Information - Exzeo intends to grant underwriters a 30-day option to purchase up to an additional 1.2 million common shares at the IPO price, less underwriting discounts and commissions [2] - Truist Securities is acting as lead left bookrunner, with Citizens Capital Markets and William Blair as joint active book-running managers, and Fifth Third Securities as a co-manager [3]

Core Viewpoint - HCI Group, Inc. announced the IPO of its subsidiary Exzeo Group, Inc., offering 8 million shares priced between $20.00 and $22.00 per share, with HCI retaining majority ownership post-IPO [1][2]. Group 1: IPO Details - Exzeo is offering 8,000,000 primary shares in its IPO, with an additional 1,200,000 shares available for underwriters [1]. - The expected IPO price range is between $20.00 and $22.00 per share [1]. - The registration statement is anticipated to become effective on November 4, 2025, unless further action is taken by the SEC [2]. Group 2: Underwriters - Truist Securities is the lead left bookrunner for the offering, with Citizens Capital Markets and William Blair as joint active book-running managers, and Fifth Third Securities as a co-manager [3]. Group 3: Company Overview - HCI Group operates through two units: one includes insurance companies and a reinsurance company, while the other, Exzeo Group, focuses on insurance technology using advanced algorithms and data analytics [6]. - HCI Group's common shares are traded on the NYSE under the ticker symbol "HCI" and are part of the Russell 2000 and S&P SmallCap 600 Index [7].

Group 1 - The article discusses the services provided by IPO Edge, which includes actionable information on growth stocks, first-look IPO filings, previews on upcoming IPOs, an IPO calendar, a database of U.S. IPOs, and a comprehensive guide to IPO investing [1]